logo
  

Horizon Therapeutics: Dazodalibep Phase 2 Rheumatoid Arthritis Trial Meets Primary Endpoint

Horizon Therapeutics plc (HZNP) announced that its phase 2, randomized, double-blinded, placebo-controlled trial of dazodalibep in rheumatoid arthritis met the primary endpoint. Dazodalibep was also well tolerated in the trial.

In the phase 2 trial, approximately 75 subjects with active, moderate-to-severe, adult-onset rheumatoid arthritis were randomized into four different dosing regimens or a placebo arm. The study met its primary endpoint of change from baseline in DAS28-CRP at day 113 in all four dazodalibep dosing arms, the company said.

"It is promising to see that the dazodalibep phase 2 rheumatoid arthritis trial not only met the primary endpoint, but that the observed treatment effect was consistently maintained," said Theresa Podrebarac, senior vice president, clinical development, Horizon.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The Federal Communications Commission or FCC has granted SpaceX Services, Inc. authorization to use its Starlink satellite internet system on vehicles in motion. SpaceX, owned by Elon Musk, is allowed to operate consumer and enterprise Ku-band Earth Stations in Motion or ESIM using frequencies allocated to the fixed satellite service. The approval would help the company to expand its services to Loud Muscle Science, LLC is recalling certain Launch Sequence products in the United States and Canada citing the presence of undeclared Tadalafil, the U.S. Food and Drug Administration said. These tainted Launch Sequence Capsule products are marketed as dietary supplements for male sexual enhancement. The U.S. Food and Drug Administration announced the intended availability of around 17 million bottles equivalent of general infant formula to be imported from New Zealand and Ireland. Under the FDA's enforcement discretion to source more infant formula to the U.S., French food company Danone SA will send 555,000 cans Aptamil Gold Plus from New Zealand.
Follow RTT